HIV support program for people with mental health and life challenges
Part of Infections, Mental health clinical trials.
This study looks at how an HIV treatment and prevention program can be improved for people who have HIV plus psychosocial challenges, especially when HIV is not well controlled. You may be able to join if your HIV is recent and higher than target, and you fit one of the specific participant groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have HIV (be HIV positive)
- Have a recent lab result in the last 12 months showing your virus is not well controlled (higher than about 20 copies per milliliter)
- Fit one of these groups: men who have sex with men who used stimulants in the past 4 months, or transgender women, or adults ages 18–26
- Be able to understand the study and give consent (not too ill or confused during the interview)
- Not have an untreated, unstable major mental illness that would prevent participation; and not be in CBT during the past year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps young gay and bisexual men with HIV in Vietnam improve their treatment outcomes and overall well-being. Researchers will work with you at your clinic to provide support and monitor your health while you're taking HIV medications.
This study tests a program that helps people with HIV manage depression and stick to their treatment. It's for adults in Cape Town, South Africa, who have a detectable HIV viral load or may have one, and who show signs of depression.
This study tests whether a program can reduce shame and stigma for people living with HIV who also have a substance use disorder. It may help you feel less judged and cope better, while supporting HIV care.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study looks at how depression and its treatment may affect the brain and immune-related body systems in people with HIV. You may be eligible if you have depression and a well-controlled HIV viral load, and you can safely complete brain MRI scans.
This study tests a new program for people living with HIV in South Africa who are struggling with food worries and emotional distress (like depression or trauma). It aims to help them take their HIV medicine more regularly and feel better overall.
Hear when a new Medication Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.